Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Accounts Payables (2017 - 2026)

Dr Reddys Laboratories has reported Accounts Payables over the past 10 years, most recently at $365.5 million for Q1 2026.

  • For Q1 2026, Accounts Payables rose 9208.65% year-over-year to $365.5 million; the TTM value through Mar 2026 reached $365.5 million, up 9208.65%, while the annual FY2026 figure was $365.5 million, 12.35% down from the prior year.
  • Accounts Payables for Q1 2026 was $365.5 million at Dr Reddys Laboratories, up from $3.9 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $372.3 million in Q1 2024 and troughed at $3.9 million in Q1 2025.
  • A 5-year average of $280.7 million and a median of $340.1 million in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: crashed 98.95% in 2025 and later soared 9208.65% in 2026.
  • Year by year, Accounts Payables stood at $340.1 million in 2022, then fell by 5.41% to $321.7 million in 2023, then grew by 15.74% to $372.3 million in 2024, then crashed by 98.95% to $3.9 million in 2025, then soared by 9208.65% to $365.5 million in 2026.
  • Business Quant data shows Accounts Payables for RDY at $365.5 million in Q1 2026, $3.9 million in Q1 2025, and $372.3 million in Q1 2024.